Education
About Us
Working with TipRanks
Follow Us
Dr. Hoenle AG (DE:HNL)
:HNL
See the Price Targets and Ratings of:
HNL Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Warburg Research
€22
Buy
126.34%
Upside
Reiterated
11/22/24
We assume that goodwill amortisation will amount to EUR 7-8m and are hence attributing the vast majority to the write-downs. At the end of FY 2023, Hönle had goodwill of EUR 18m in its balance sheet. Of this roughly EUR 6m can be attributed to Hoenle AG and Raesch Malta respectively and another EUR 5m to Sterilsystems. As the disinfection business is not expected to be affected by the measures, the sources of the goodwill amortisation are expected to have been Hoenle AG, with its higher exposure to printing customers, and Raesch Malta, where profitability has been stable but at low levels. Organically, Hönle reached sales of EUR 98m and a slightly positive EBIT in FY 2024, which is in line with the expectation. The operating development is expected to have troughed in the last FY.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Warburg Research
€22
Buy
126.34%
Upside
Reiterated
11/22/24
We assume that goodwill amortisation will amount to EUR 7-8m and are hence attributing the vast majority to the write-downs. At the end of FY 2023, Hönle had goodwill of EUR 18m in its balance sheet. Of this roughly EUR 6m can be attributed to Hoenle AG and Raesch Malta respectively and another EUR 5m to Sterilsystems. As the disinfection business is not expected to be affected by the measures, the sources of the goodwill amortisation are expected to have been Hoenle AG, with its higher exposure to printing customers, and Raesch Malta, where profitability has been stable but at low levels. Organically, Hönle reached sales of EUR 98m and a slightly positive EBIT in FY 2024, which is in line with the expectation. The operating development is expected to have troughed in the last FY.
HNL Analyst Recommendation Trends
Rating
May 23
Jun 23
Aug 23
Oct 23
Nov 24
Strong Buy
2
2
3
3
3
Buy
2
1
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
HNL Stock Forecast FAQ
What is DE:HNL’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Hoenle AG’s 12-month average price target is €22.00.
What is DE:HNL’s upside potential, based on the analysts’ average price target?
Dr. Hoenle AG has 126.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dr. Hoenle AG a Buy, Sell or Hold?
Dr. Hoenle AG has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Dr. Hoenle AG’s share price target?
The average share price target for Dr. Hoenle AG is €22.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €22.00 ,and the lowest forecast is €22.00. The average share price target represents 126.34% Increase from the current price of €9.72.
The highest analyst share price target is €22.00 ,and the lowest forecast is €22.00. The average share price target represents 126.34% Increase from the current price of €9.72.
What do analysts say about Dr. Hoenle AG?
Dr. Hoenle AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Dr. Hoenle AG?
To buy shares of DE:HNL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.